Drugs Approved by the FDA

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Teva Pharmaceutical
Approval Status: Approved January 1997
Treatment for: Parkinson’s disease

General Information

Selegiline has been approved for the treatment of Parkinson's disease. Selegiline is a generic equivalent of Somerset’s Eldepryl tablets, a drug for the treatment of Parkinson’s disease. Other generic versions of this product have been introduced over the last several months.